Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 28 of about 41 companies and 8 funds for Stephen Dean�
Company Exchange Symbol Last price Quote change Market cap
Wells Fargo & Co NYSE WFC 53.24 +0.73 (1.39%) 274.12B
Wells Fargo & Company is a bank holding company. The Company is a diversified financial services company. It has three operating segments: Community Banking ...
Executive:
Stephen W.
ImmunoGen, Inc. NASDAQ IMGN 11.34 +0.04 (0.35%) 970.76M
ImmunoGen, Inc. (ImmunoGen) develops targeted, antibody-based therapeutics for the treatment of cancer. ImmunoGen designs linkers that enable antibody-based ...
Executive:
Stephen C. McCluski.
Tyson Foods, Inc. NYSE TSN 38.78 +0.35 (0.91%) 14.43B
Tyson Foods, Inc. is a food production company. The Company produces, distributes and markets chicken, beef, pork, prepared foods and related allied ...
Executive:
Stephen R. Stouffer
Wells Fargo & Co OTCMKTS WFCNP 0.570 0.000 (0.00%) 274.12B
Wells Fargo & Company is a bank holding company. The Company is a diversified financial services company. It has three operating segments: Community Banking ...
Executive:
Stephen W.
Wells Fargo & Co NYSE WFC-L 1,200.12 +0.07 (0.01%) 273.69B
Wells Fargo & Company is a bank holding company. The Company is a diversified financial services company. It has three operating segments: Community Banking ...
Executive:
Stephen W.
Pengrowth Energy Corp (USA) NYSE PGH 5.64 -0.02 (-0.42%) 3.01B
Pengrowth Energy Corporation (Pengrowth) is engaged in the development, production and acquisition of, and the exploration for, oil and natural gas reserves ...
Executive:
Stephen J.
Abraxas Petroleum Corp. NASDAQ AXAS 5.73 -0.11 (-1.88%) 615.45M
Abraxas Petroleum Corporation is an independent energy company primarily engaged in the acquisition, exploitation, development and production of oil and gas ...
Executive:
Stephen T.
WaferGen Bio-systems, Inc. NASDAQ WGBS 4.30 -0.10 (-2.27%) 4.13M
WaferGen Bio-systems, Inc. (WBSI) is engaged in the development, manufacture and marketing of laboratory analytical instruments for cell biology, ...
Executive:
Joel Stephen Kanter
Plexus Corp. NASDAQ PLXS 39.18 +0.17 (0.44%) 1.32B
Plexus Corp. (Plexus) and its subsidiaries deliver solutions to its customers through its Product Realization Value Stream. The Company's customer-focused ...
Executive:
Stephen P. Cortinovis
Alexandria Real Estate Equities Inc NYSE ARE 75.31 -0.97 (-1.27%) 5.47B
Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT). The Company is an owner and REIT, and life science real estate company, ...
Executive:
Stephen A.
Transfield Services Limited ASX TSE 1.61 +0.01 (0.94%) 825.08M
Transfield Services Limited is engaged in the provision of operations and maintenance, asset management, project and capital management outsourcing and ...
Executive:
Stephen Philips
Boulder Brands Inc NASDAQ BDBD 14.49 -0.23 (-1.56%) 897.99M
Boulder Brands, Inc. is a supplier of gluten-free and health and wellness products in the United States and Canada. The Company distributes its products in ...
Executive:
Stephen B. Hughes
Diamcor Mining Inc. CVE DMI 1.41 -0.01 (-0.70%) 53.36M
Diamcor Mining Inc. is a junior mining and exploration company. The Company principal business is the identification, acquisition, exploration, evaluation, ...
Executive:
Stephen E. Haggerty.
Navigant Consulting, Inc. NYSE NCI 15.43 +0.29 (1.92%) 739.43M
Navigant Consulting, Inc. is an independent specialty consulting firm. Professional services include dispute, investigative, economic, operational, ...
Landec Corporation NASDAQ LNDC 12.64 +0.06 (0.48%) 337.67M
Landec Corporation (Landec) designs, develops, manufactures and sells polymer products for food and agricultural products, medical devices and licensed ...
Executive:
Stephen E. Halprin
REGAL-BELOIT CORPORATION NYSE RBC 68.83 -0.42 (-0.61%) 3.13B
Regal Beloit Corporation is a global manufacturer of electric motors and controls, electric generators and controls, and mechanical motion control products.
Executive:
Stephen M.
Cytomedix, Inc. OTCMKTS CMXI 0.440 -0.006 (-1.35%) 54.74M
Cytomedix, Inc. (Cytomedix) is a regenerative therapies company marketing and developing products within the United States and internationally .
Executive:
Stephen N. Keith MD
Canadian Tire Corporation Limited TSE CTC.A 116.72 -0.15 (-0.13%) 9.45B
Canadian Tire Corporation, Limited comprises two main business operations that offer a range of retail goods and services, including general merchandise, ...
Executive:
Stephen G. Wetmore.
Boulder Growth & Income Fund Inc NYSE BIF 8.99 +0.09 (1.04%) 226.72M
Boulder Growth & Income Fund, Inc. (the Fund) is a non-diversified, closed-end management company. The Fund's investment objective is total return.
Executive:
Stephen C. Miller Esq.
Sherritt International Corporation TSE S 3.65 -0.05 (-1.35%) 1.09B
Sherritt International Corporation (Sherritt) is a Canada-based natural resource company, which operates in Canada and Cuba. The Company, through its ...
Executive:
Harold S. Stephen
Show all 41 companies »
Mutual Fund Symbol Nav Nav change
CI Cambridge Canadian Growth Companies Fund Class A CIG11108 20.83 0.00 (0.00%)
The fundamental investment objective of Cambridge Canadian Growth Companies Fund is to provide long-term capital growth by investing primarily in common ...
Executive:
Stephen Groff.
CI Cambridge Pure Canadian Equity Fund Class A CIG11109 22.30 -0.01 (-0.04%)
The fundamental investment objective of Castlerock Pure Canadian Equity Fund is to achieve long-term capital growth by investing, directly or indirectly, ...
Executive:
Stephen Groff.
CI Cambridge Pure Canadian Equity Fund Class AT6 CIG11609 27.48 -0.05 (-0.18%)
The fundamental investment objective of Castlerock Pure Canadian Equity Fund is to achieve long-term capital growth by investing, directly or indirectly, ...
Executive:
Stephen Groff.
CI Cambridge Canadian Growth Companies Fund Class B CIG11208 16.61 0.00 (0.00%)
The fundamental investment objective of Castlerock Canadian Growth Companies Fund is to provide long-term capital growth by investing primarily in common ...
Executive:
Stephen Groff.
CI Cambridge Canadian Growth Companies Fund Class BT6 CIG11708 21.88 0.00 (0.00%)
The fundamental investment objective of Castlerock Canadian Growth Companies Fund is to provide long-term capital growth by investing primarily in common ...
Executive:
Stephen Groff.
CI Cambridge Canadian Growth Companies Fund Class AT6 CIG11608 25.62 +0.04 (0.16%)
The fundamental investment objective of Cambridge Canadian Growth Companies Fund is to provide long-term capital growth by investing primarily in common ...
Executive:
Stephen Groff.
CI Cambridge Pure Canadian Equity O CIG18158 13.10 -0.01 (-0.08%)
The fundamental investment objective of Castlerock Pure Canadian Equity Fund is to achieve long-term capital growth by investing, directly or indirectly, ...
Executive:
Stephen Groff.
CI Cambridge Pure Canadian Equity E CIG16158 13.08 -0.01 (-0.08%)
The fundamental investment objective of Castlerock Pure Canadian Equity Fund is to achieve long-term capital growth by investing, directly or indirectly, ...
Executive:
Stephen Groff.